Your browser doesn't support javascript.
loading
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis.
Dand, Nick; Duckworth, Michael; Baudry, David; Russell, Alice; Curtis, Charles J; Lee, Sang Hyuck; Evans, Ian; Mason, Kayleigh J; Alsharqi, Ali; Becher, Gabrielle; Burden, A David; Goodwin, Richard G; McKenna, Kevin; Murphy, Ruth; Perera, Gayathri K; Rotarescu, Radu; Wahie, Shyamal; Wright, Andrew; Reynolds, Nick J; Warren, Richard B; Griffiths, Christopher E M; Smith, Catherine H; Simpson, Michael A; Barker, Jonathan N.
Afiliação
  • Dand N; School of Basic & Medical Biosciences, London, United Kingdom.
  • Duckworth M; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom.
  • Baudry D; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom.
  • Russell A; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom.
  • Curtis CJ; NIHR Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom; Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Lee SH; NIHR Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom; Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Evans I; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, United Kingdom.
  • Mason KJ; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, United Kingdom.
  • Alsharqi A; Royal Liverpool and Brodgreen University Hospital Trusts, Liverpool, United Kingdom.
  • Becher G; Alan Lyell Centre for Dermatology, West Glasgow ACH, Glasgow, United Kingdom.
  • Burden AD; Institute of Infection, Inflammation and Immunity, University of Glasgow, Glasgow, United Kingdom.
  • Goodwin RG; Aneurin Bevan University Health Board, Gwent, United Kingdom.
  • McKenna K; Department of Dermatology, Belfast City Hospital, Belfast, United Kingdom.
  • Murphy R; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom; Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Perera GK; Chelsea & Westminster Hospital NHS Foundation Trust, West Middlesex University Hospital, London, United Kingdom.
  • Rotarescu R; University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom.
  • Wahie S; University Hospital North Durham, Durham, United Kingdom.
  • Wright A; Centre for Skin Science, University of Bradford, Bradford, United Kingdom; Dermatology Department, St Luke's Hospital, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom.
  • Reynolds NJ; Dermatological Sciences, Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne, United Kingdom; Department of Dermatology, Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; Newcastle MRC/EPSRC Molecular Patholo
  • Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, United Kingdom.
  • Griffiths CEM; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, United Kingdom.
  • Smith CH; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom.
  • Simpson MA; School of Basic & Medical Biosciences, London, United Kingdom. Electronic address: michael.simpson@kcl.ac.uk.
  • Barker JN; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom. Electronic address: jonathan.barker@kcl.ac.uk.
J Allergy Clin Immunol ; 143(6): 2120-2130, 2019 06.
Article em En | MEDLINE | ID: mdl-30578879
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Terapia Biológica / Antígenos HLA-C / Biomarcadores Farmacológicos / Adalimumab / Ustekinumab / Genótipo Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Terapia Biológica / Antígenos HLA-C / Biomarcadores Farmacológicos / Adalimumab / Ustekinumab / Genótipo Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article